Phenylbenzohydrazides Obtained from Isatoic Anhydride Present Anti-Inflammatory Activity in Vivo and in Vitro
Authors:
- João Pedro Barros de PaivaJPJoão Pedro Barros de Paiva
- Millena Santos CordeiroMCMillena Santos Cordeiro
- Patricia Ribeiro de Carvalho FrançaPFPatricia Ribeiro de Carvalho França
- Luiz Octavio Pereira BrancoLBLuiz Octavio Pereira Branco
- Isabela Souza dos SantosISIsabela Souza dos Santos
- Nanashara Figueiredo ReisNRNanashara Figueiredo Reis
- Patrick Pedro PimentelPPPatrick Pedro Pimentel
- Thais Biondino Sardella GiornoTGThais Biondino Sardella Giorno
- Evanoel Crizanto de LimaELEvanoel Crizanto de Lima
- Patricia Dias FernandesPatricia Dias Fernandes
Preprint
- 31 October 2022
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Despite the existence of a wide variety of anti-inflammatory drugs, the vast majority are classified as steroidal or non-steroidal. Both classes with many side effects that limit usage. Thus, the search for new molecules with anti-inflammatory potential is still important. Methods: Five phenylbenzohydrazides were synthetized and evaluated in pre-clinical models of acute inflammation in vivo and in vitro. Results: Substances significantly reduced cell migration induced by carrageenan. It was also observed an intense inhibition in protein extravasation and cytokines (IL-6, IL-1β, and TNF-α) production as well as nitric oxide reduction. INL-11 demonstrated to be the most potent since the reduction was significant even when compared with dexamethasone. In vitro INLs also reduced cytokines and NO production and iNOS activity. INL-11 was the most effective in reducing cell migration in vitro. Conclusions: our data suggest that these substances are suitable for further development to new series of compounds that could lead to new hits and future drug prototypes for anti-inflammatory conditions.Keywords
All Related Versions
- Version 1, 2022-10-31, Preprints
- Published version: Biomolecules, 12 (12), 1901.